EUVIMEDEUVIMED entdecken
Crossref

Formulation and Evaluation of Fast Dissolving Tablet of Meclizine HCl by Creating an Amorphous Solid Dispersion using a Novel Polymer Apinovex™ LV

Ms. Archana Khot, Dr. Sujit Kakade, Dr. Ganesh Nigade, Mrs. Trusha Shangrapawar, Dr. Ashok Bhosale

International Journal of Drug Delivery Technology · 05.05.2026 · 16 (24s)

DOI: 10.25258/ijddt.16.24s.63 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 05.05.2026. Verfasst von Ms. Archana Khot und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Meclizine hydrochloride (HCl), a first-generation antihistamine, is commonly prescribed for motion sickness and vertigo. However, its poor aqueous solubility limits its oral bioavailability and delays its onset of action, creating a challenge for effective patient care. Enhancing its solubility and developing patient-friendly dosage forms are therefore crucial.

Objective

The study aimed to improve the solubility and dissolution rate of Meclizine HCl by formulating fast dissolving tablets (FDTs) using amorphous solid dispersions (ASDs) with conventional and novel polymers.

Methods

Amorphous solid dispersions were prepared using two polymers—polyvinylpyrrolidone K30 (PVP K30) and Apinovex™ LV—through solvent evaporation and spray-drying techniques in varying drug-to-polymer ratios. The optimized ASDs were compressed into FDTs and evaluated for solubility, disintegration time, drug release, and stability as per pharmacopeial guidelines.

Findings

Among the formulations, the spray-dried ASD prepared with Apinovex™ at a 1:2 drug-to-polymer ratio (FSD12) demonstrated the highest solubility enhancement (~20-fold in phosphate buffer). The corresponding FDT batch (F4) showed rapid disintegration (39 ± 3 seconds) and superior drug release (97.5 ± 2.91% within 30 minutes). Stability studies confirmed that the optimized formulation remained robust over three months under accelerated conditions.

Conclusion

The findings establish Apinovex™ as a promising carrier for the development of fast dissolving tablets of Meclizine HCl. The optimized formulation significantly improved solubility, dissolution rate, and patient compliance, offering a practical strategy for enhancing the bioavailability of poorly soluble drugs.

Zitieren

APA

Khot, M. A., Kakade, D. S., Nigade, D. G., Shangrapawar, M. T., & Bhosale, D. A. (2026). Formulation and Evaluation of Fast Dissolving Tablet of Meclizine HCl by Creating an Amorphous Solid Dispersion using a Novel Polymer Apinovex™ LV. International Journal of Drug Delivery Technology, 16(24s). https://doi.org/10.25258/ijddt.16.24s.63

Vancouver

Khot MA, Kakade DS, Nigade DG, Shangrapawar MT, Bhosale DA. Formulation and Evaluation of Fast Dissolving Tablet of Meclizine HCl by Creating an Amorphous Solid Dispersion using a Novel Polymer Apinovex™ LV. International Journal of Drug Delivery Technology. 2026;16(24s). doi:10.25258/ijddt.16.24s.63

BibTeX
@article{Khot2026,
  author = {Khot, Ms. Archana and Kakade, Dr. Sujit and Nigade, Dr. Ganesh and Shangrapawar, Mrs. Trusha and Bhosale, Dr. Ashok},
  title = {Formulation and Evaluation of Fast Dissolving Tablet of Meclizine HCl by Creating an Amorphous Solid Dispersion using a Novel Polymer Apinovex™ LV},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {24s},
  doi = {10.25258/ijddt.16.24s.63}
}
Kostenlos starten →